Key results 2015

For none of the eight key variables studied did the Icelandic students report prevalence rates above the overall average. Lifetime use of illicit drugs other than cannabis, non-prescription use of tranquillisers or sedatives and lifetime use of NPS were almost in line with the overall results. However, it should be kept in mind that use of these substances was rather uncommon to begin with. For the five remaining variables the Icelandic results were definitely below the ESPAD average though. Reported lifetime use of cannabis and inhalants in Iceland were less than half the overall average, while last-30-day cigarette use and heavy episodic drinking were only one quarter of the ESPAD average. The largest difference, in relative terms as well as in percentage points, was noted for alcohol use in the last 30 days (9 % compared to 48 %). In the ESPAD context Iceland is definitely a low-prevalence country when it comes to substance use. In fact, no other 2015 ESPAD country displayed prevalence rates so low.

Country facts:
Area: 102800 km2
Population: 318 000

Country contacts: 

Ársæll Már Arnarsson 
Principal Investigator

Center for Prevention Studies
University of Akureyri
Solborg v/Nordurslod
600 Akureyri
Tel: +354 4608000
Mob: +354 8463223